The goal of this clinical trial is to evaluate the use of glucose sensors in pregnant women with type 2 diabetes to improve insulin regulation, pregnancy and birth outcomes, and enhance quality of life and satisfaction with treatment. The main questions it aims to answer are: * Does the use of glucose sensors during pregnancy lead to a clinically significant reduction in HbA1c by 0.3% at 36 weeks gestation compared to the control group? * Does the use of glucose sensors during pregnancy result in a clinically significant reduction in mean SD-score for birth weight deviation in newborns compared to the control group? Researchers will compare the group of women using glucose sensors during pregnancy to a historical control group receiving routine care to see if the sensor improves pregnancy outcomes, glucose control, and birth weights. Participants will: * Use a glucose sensor from before 14 weeks of pregnancy until 4-6 weeks postpartum. * Receive training on how to use the sensor and access ongoing support as needed. * Have a follow-up appointment 4-6 weeks postpartum, including a consultation for advice on medical treatment and further management of diabetes after birth.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
200
Pregnant women with type 2 diabetes are given a sensor \< week 14 of their pregnancy and will use it until 4-6 post partum. They will receive training in how to use the sensor, and support when needed.
HbA1c at end of pregnancy (week 36 of pregnancy)
Time frame: baseline < week 14 of pregnancy, follow up week 36 of pregnancy
child birth weight SD-score
Time frame: at time of birth
TIR, TAR, TBR
Percentage of time in time in range, time above range and time below range during their pregnancy.
Time frame: from enrollment to 4-6 weeks post partum
Mean glucose
Sensor specific data
Time frame: from enrollment to 4-6 weeks post partum
Womens gestational wheight gain
weight gain during throughout pregnancy
Time frame: from enrollment to birth
Hypoglykemia among newborn
Hypoglykemia among newborn
Time frame: at time of birth
Pregnancy related complications
increased blood pressure and preeclampsia
Time frame: from enrollment to birth
Birth related complications
c-section, early birth
Time frame: at time of birth
Problem Areas in Diabetes (PAID)
Diabetes stress
Time frame: Baseline, week 28, 4-6 weeks post partum
World Health Organisation - Five Well-Being Index (WHO-5)
quality of life
Time frame: Baseline, week 28, 4-6 weeks post partum
12-Item Short-Form (SF12)
Health status
Time frame: Baseline, week 28, 4-6 weeks post partum
Patient Assessment of Cronic Illness Care (PACIC)
Satisfaction with care
Time frame: Baseline, week 28, 4-6 weeks post partum
Glucose Monitoring Satisfaction Survey (GMSS)
Satisfaction with method used for glucose measuring
Time frame: Baseline, week 28, 4-6 weeks post partum
Pregnancy Physical Activity Questionnaire (PPAQ-DK
Physical activity in pregnancy
Time frame: Baseline, week 28
Diet items from the National Danish Birth Cohort
Pregnancy specific questions related to diet
Time frame: Baseline, week 28
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.